BioMedha specializes in preclinical drug discovery biology. We offer cost-effective, high-quality, bespoke, bioscience services to advance your drug discovery pipeline. Our main aim is to simplify your early-stage drug discovery; transfer your In vitro biology projects to our team who will advance your drug discovery using our robust platforms tailored to your needs.

Robust In vitro assays are the foundation of effective drug discovery pipeline, and our custom assay development and screening services provide you with consistent performance. BioMedha facilitates the development of such assays across multiple platforms for your screening needs supporting Target Validation, Hit Identification, Lead Optimisation, Candidate Selection, and Mechanism Of Action.

We work on both an FTE and fee-for-service basis at very competitive rates. Experienced scientists are assigned to specific projects to deliver impactful results efficiently. Contact us to learn more about how we can best support your projects.